# Biotech Daily Digest — 2025-12-10

**48 items from 4 sources**

## Summary by Source

- Eli Lilly Press Releases: 1 item
- Endpoints News: 11 items
- Fierce Biotech: 5 items
- arXiv q-bio: 31 items


## Eli Lilly Press Releases

- **[Lilly to build $6 billion facility to manufacture active pharmaceutical ingredients in Alabama](https://investor.lilly.com/news-releases/news-release-details/lilly-build-6-billion-facility-manufacture-active-pharmaceutical)**  
  _Tue, 09 Dec 2025 15:30:00 -0500_  
  Huntsville site will focus on domestic production of small molecule synthetic and peptide medicines, including Lilly's oral GLP-1 , orforglipron Company plans to create 3,450 manufacturing and construction jobs at Lilly's ninth U.S. manufacturing site announced since 2020 INDIANAPOLIS , Dec.


## Endpoints News

- **[#SABCS25: Roche’s breast cancer pill cuts post-surgery disease recurrence risk by 30%](https://endpoints.news/sabcs25-roches-breast-cancer-pill-cuts-post-surgery-disease-recurrence-risk-by-30/)**  
  _Wed, 10 Dec 2025 13:15:32 +0000_  
  Patients who were given Roche’s experimental breast cancer pill directly after having surgery were 30% less likely to have invasive disease recurrence than those who were given standard of care, according to interim data presented ...

- **[D3 Bio raises $108M to take next-gen KRAS G12C drug into Phase 3](https://endpoints.news/d3-bio-raises-108m-to-take-next-gen-kras-g12c-drug-into-phase-3/)**  
  _Wed, 10 Dec 2025 11:40:43 +0000_  
  D3 Bio has secured $108 million in a Series B fundraise, with the main goal of advancing its lead drug candidate targeting KRAS G12C into global registrational trials.

 The Shanghai-based biotech plans to evaluate the ...

- **[BlossomHill gets another $84M for macrocyclic approach to EGFR](https://endpoints.news/blossomhill-gets-another-84m-for-macrocyclic-approach-to-egfr/)**  
  _Wed, 10 Dec 2025 11:30:14 +0000_  
  With two cancer drugs in clinical testing, BlossomHill Therapeutics has convinced investors to fuel the San Diego startup with another $84 million in its attempt to take on AstraZeneca's EGFR inhibitor Tagrisso.

 CEO Jean Cui ...

- **[Eli Lilly earmarks $6B for GLP-1 pill factory in Alabama](https://endpoints.news/eli-lilly-earmarks-6b-for-glp-1-pill-factory-in-alabama/)**  
  _Tue, 09 Dec 2025 20:30:05 +0000_  
  Eli Lilly will spend $6 billion to build an orforglipron factory in Huntsville, AL, the third of four new US sites the pharma giant plans to announce this year.

 As well as manufacturing the oral ...

- **[#ASH25: New data from Gilead, J&J set up a bispecific, CAR-T rivalry](https://endpoints.news/ash25-new-data-from-gilead-jj-set-up-a-bispecific-car-t-rivalry/)**  
  _Tue, 09 Dec 2025 19:17:45 +0000_  
  ORLANDO, Fla. — Clinical trials in multiple myeloma continue to rapidly progress, and nowhere was this more apparent than at the American Society of Hematology’s annual meeting. Companies like Johnson & Johnson, Gilead and Arcellx were ...

- **[J&J-backed Cellular Origins raises $40M for cell therapy manufacturing](https://endpoints.news/jj-backed-cellular-origins-raises-40m-for-cell-therapy-manufacturing/)**  
  _Tue, 09 Dec 2025 17:53:07 +0000_  
  UK-based cell therapy manufacturer Cellular Origins has raised $40 million in an over-subscribed Series A to expand to the US and secure more company partnerships.

 The round was led by Johnson & Johnson’s venture capital ...

- **[SanegeneBio raises $110M in follow-up to metabolic deal with Lilly](https://endpoints.news/chinas-sanegenebio-raises-110m-in-follow-up-to-metabolic-deal-with-lilly/)**  
  _Tue, 09 Dec 2025 16:43:39 +0000_  
  Just a month after announcing a deal with Eli Lilly to work on RNAi drugs for metabolic diseases, SanegeneBio has disclosed a $110 million Series B round to fund its work ...

- **[Novartis to partner with AI-focused Relation on atopic diseases](https://endpoints.news/novartis-to-partner-with-relation-therapeutics-on-atopic-diseases/)**  
  _Tue, 09 Dec 2025 16:19:37 +0000_  
  Novartis has inked a deal with UK biotech Relation to discover and develop new drugs for certain immune diseases.

 This is the second deal with a large pharmaceutical company for Relation, which previously

- **[#ASH25: Early in vivo CAR-T results like Kelonia's elicit excitement across the field](https://endpoints.news/ash25-early-in-vivo-car-t-results-like-kelonias-elicit-excitement-across-the-field/)**  
  _Tue, 09 Dec 2025 16:04:26 +0000_  
  ORLANDO, Fla. — A single, ready-made infusion got rid of any detectable cancer cells in four multiple myeloma patients in Australia, Kelonia Therapeutics reported as part of its first clinical trial readout.

 The infusion is designed ...

- **[EpilepsyGTx gets $33M to test epilepsy gene therapy in Phase 1/2a](https://endpoints.news/epilepsygtx-gets-33m-to-test-epilepsy-gene-therapy-in-phase-1-2a/)**  
  _Tue, 09 Dec 2025 16:00:08 +0000_  
  After more than two years of pitching investors, a London upstart with two current employees has pulled through with a $33 million Series A to see if it can crack into a relatively niche pocket ...

- **[Seven biotechs eye $2.3B in public offerings after data readouts](https://endpoints.news/seven-biotechs-eye-2-3b-in-public-offerings-after-data-readouts/)**  
  _Tue, 09 Dec 2025 15:43:26 +0000_  
  Investors can't seem to get enough of biotech stocks.

 On Monday evening and Tuesday morning, seven different biopharma companies announced plans to raise a total of $2.3 billion through stock sales, offering shares to investors ...


## Fierce Biotech

- **[<a href="https://www.fiercebiotech.com/biotech/roche-links-oral-serd-30-breast-cancer-risk-reduction-phase-3-adjuvant-trial" hreflang="en">Roche links oral SERD to 30% breast cancer risk reduction in phase 3 adjuvant trial</a>](https://www.fiercebiotech.com/biotech/roche-links-oral-serd-30-breast-cancer-risk-reduction-phase-3-adjuvant-trial)**  
  _Dec 10, 2025 6:06am_  
  Roche has lifted the lid on the data behind its second phase 3 giredestrant win, linking the oral selective estrogen receptor degrader to a 30% reduction in the risk of invasive disease recurrence or death.

- **[<a href="https://www.fiercebiotech.com/biotech/chinese-biotech-helmed-az-veteran-reels-108-series-b-kras-inhibitor-phase-3-plans" hreflang="en">Chinese biotech led by AstraZeneca veteran reels in $108M for KRAS phase 3 plans</a>](https://www.fiercebiotech.com/biotech/chinese-biotech-helmed-az-veteran-reels-108-series-b-kras-inhibitor-phase-3-plans)**  
  _Dec 10, 2025 3:46am_  
  A Chinese biotech helmed by an AstraZeneca veteran has secured $108 million in series B funds, which the company will use to advance its lead KRAS inhibitor into phase 3 studies.

- **[<a href="https://www.fiercebiotech.com/biotech/strong-words-big-smiles-enduring-activism-and-cautious-optimism-american-society-hematology" hreflang="en">Rainbows, pickleball and puppies: Inside the ‘enduring activism’ and ‘cautious optimism’ at ASH 2025</a>](https://www.fiercebiotech.com/biotech/strong-words-big-smiles-enduring-activism-and-cautious-optimism-american-society-hematology)**  
  _Dec 9, 2025 1:42pm_  
  People come to Orlando to escape. With Disney World, SeaWorld and Universal Studios all in the area, there are endless opportunities to leave behind the challenges of the real world for a bit of relaxation and maybe a little bit of magic.

- **[<a href="https://www.fiercebiotech.com/medtech/medline-sets-terms-massive-537b-nasdaq-ipo" hreflang="en">Medline sets terms for massive $5.37B Nasdaq IPO</a>](https://www.fiercebiotech.com/medtech/medline-sets-terms-massive-537b-nasdaq-ipo)**  
  _Dec 9, 2025 11:20am_  
  The medical device manufacturing and distribution giant could claim a valuation of about $55 billion if it reaches the top of its range.

- **[<a href="https://www.fiercebiotech.com/biotech/ash-exicure-rebounds-phase-2-win-90-blood-cell-mobilization-myeloma" hreflang="en">ASH: Exicure rebounds with phase 2 win, seeing 90% blood cell mobilization in myeloma</a>](https://www.fiercebiotech.com/biotech/ash-exicure-rebounds-phase-2-win-90-blood-cell-mobilization-myeloma)**  
  _Dec 9, 2025 10:16am_  
  Exicure’s investigational small molecule succeeded in mobilizing key blood-forming cells in almost 90% of patients in a phase 2 multiple myeloma trial, paving the way for smoother and more effective autologous stem cell transplants.


## arXiv q-bio

- **[State and Parameter Estimation for a Neural Model of Local Field Potentials](https://arxiv.org/abs/2512.07842)**  
  _Wed, 10 Dec 2025 00:00:00 -0500_  
  arXiv:2512.07842v1 Announce Type: new 
Abstract: The study of cortical dynamics during different states such as decision making, sleep and movement, is an important topic in Neuroscience. Modelling efforts aim to relate the neural rhythms present in cortical recordings to the underlying dynamics responsible for their…

- **[Manifolds and Modules: How Function Develops in a Neural Foundation Model](https://arxiv.org/abs/2512.07869)**  
  _Wed, 10 Dec 2025 00:00:00 -0500_  
  arXiv:2512.07869v1 Announce Type: new 
Abstract: Foundation models have shown remarkable success in fitting biological visual systems; however, their black-box nature inherently limits their utility for under- standing brain function. Here, we peek inside a SOTA foundation model of neural activity (Wang et al., 2025)…

- **[Revised comment on the paper titled "The Origin of Quantum Mechanical Statistics: Insights from Research on Human Language](https://arxiv.org/abs/2512.07881)**  
  _Wed, 10 Dec 2025 00:00:00 -0500_  
  arXiv:2512.07881v1 Announce Type: new 
Abstract: This short note comments on \citet{Aerts2024Origin}, which proposes that ranked word frequencies in texts should be read through the lens of Bose--Einstein (BE) statistics and even used to illuminate the origin of quantum statistics in physics. The core message here is…

- **[Harmonizing Community Science Datasets to Model Highly Pathogenic Avian Influenza (HPAI) in Birds in the Subantarctic](https://arxiv.org/abs/2512.07907)**  
  _Wed, 10 Dec 2025 00:00:00 -0500_  
  arXiv:2512.07907v1 Announce Type: new 
Abstract: Community science observational datasets are useful in epidemiology and ecology for modeling species distributions, but the heterogeneous nature of the data presents significant challenges for standardization, data quality assurance and control, and workflow management.…

- **[A Semi-Supervised Inf-Net Framework for CT-Based Lung Nodule Analysis with a Conceptual Extension Toward Genomic Integration](https://arxiv.org/abs/2512.07912)**  
  _Wed, 10 Dec 2025 00:00:00 -0500_  
  arXiv:2512.07912v1 Announce Type: new 
Abstract: Lung cancer is a primary contributor to cancer-related mortality globally, highlighting the necessity for precise early detection of pulmonary nodules through low-dose CT (LDCT) imaging. Deep learning methods have improved nodule detection and classification; however, t…

- **[Subcellular proteome niche discovery using semi-supervised functional clustering](https://arxiv.org/abs/2512.08087)**  
  _Wed, 10 Dec 2025 00:00:00 -0500_  
  arXiv:2512.08087v1 Announce Type: new 
Abstract: Intracellular compartmentalization of proteins underpins their function and the metabolic processes they sustain. Various mass spectrometry-based proteomics methods (subcellular spatial proteomics) now allow high throughput subcellular protein localization. Yet, the cur…

- **[needLR: Long-read structural variant annotation with population-scale frequency estimation](https://arxiv.org/abs/2512.08175)**  
  _Wed, 10 Dec 2025 00:00:00 -0500_  
  arXiv:2512.08175v1 Announce Type: new 
Abstract: Summary: We present needLR, a structural variant (SV) annotation tool that can be used for filtering and prioritization of candidate pathogenic SVs from long-read sequencing data using population allele frequencies, annotations for genomic context, and gene-phenotype as…

- **[Spatially-extended Flow Phixer (SpeF-Phixer): A Spatially Extended $\varphi$-Mixing Framework for Gene Regulatory Causal Inference in Spatial Gene Field](https://arxiv.org/abs/2512.08202)**  
  _Wed, 10 Dec 2025 00:00:00 -0500_  
  arXiv:2512.08202v1 Announce Type: new 
Abstract: Background and objective: Spatial transcriptomics provides rich spatial context but lacks sufficient resolution for large-scale causal inference. We developed SpeF-Phixer, a spatially extended phi-mixing framework integrating whole-slide image (WSI)-derived spatial cell…

- **[ImmunoNX: a robust bioinformatics workflow to support personalized neoantigen vaccine trials](https://arxiv.org/abs/2512.08226)**  
  _Wed, 10 Dec 2025 00:00:00 -0500_  
  arXiv:2512.08226v1 Announce Type: new 
Abstract: Personalized neoantigen vaccines represent a promising immunotherapy approach that harnesses tumor-specific antigens to stimulate anti-tumor immune responses. However, the design of these vaccines requires sophisticated computational workflows to predict and prioritize…

- **[Joint economic and epidemiological modelling of alternative pandemic response strategies](https://arxiv.org/abs/2512.08355)**  
  _Wed, 10 Dec 2025 00:00:00 -0500_  
  arXiv:2512.08355v1 Announce Type: new 
Abstract: In an emerging pandemic, policymakers need to make important decisions with limited information, for example choosing between a mitigation, suppression or elimination strategy. These strategies may require trade-offs to be made between the health impact of the pandemic…

- **[Integrating Coarse-Grained Simulations and Deep Learning to Unveil Entropy-Driven dsRNA Unwinding by DDX3X](https://arxiv.org/abs/2512.08367)**  
  _Wed, 10 Dec 2025 00:00:00 -0500_  
  arXiv:2512.08367v1 Announce Type: new 
Abstract: DEAD-box RNA helicases (DDXs) are essential RNA metabolism regulators that typically unwind dsRNA in an ATP-dependent manner. However, recent studies show some DDXs can also unwind dsRNA without ATP, a phenomenon that remains poorly understood. Here, we developed HelixT…

- **[Fused Gromov-Wasserstein Contrastive Learning for Effective Enzyme-Reaction Screening](https://arxiv.org/abs/2512.08508)**  
  _Wed, 10 Dec 2025 00:00:00 -0500_  
  arXiv:2512.08508v1 Announce Type: new 
Abstract: Enzymes are crucial catalysts that enable a wide range of biochemical reactions. Efficiently identifying specific enzymes from vast protein libraries is essential for advancing biocatalysis. Traditional computational methods for enzyme screening and retrieval are time-c…

- **[Flow-Based Modelling of Population Dynamics with Consecutive Continuous Mutations](https://arxiv.org/abs/2512.08660)**  
  _Wed, 10 Dec 2025 00:00:00 -0500_  
  arXiv:2512.08660v1 Announce Type: new 
Abstract: We develop a continuous mathematical model of population dynamics that describes the sequential emergence of new genotypes under limited resources. The framework models genotype density as a nonlinear flow in mutation space, combining transport driven by a time-dependen…

- **[Sleep effects on brain, cognition, and mental health during adolescence are mediated by the glymphatic system](https://arxiv.org/abs/2512.08704)**  
  _Wed, 10 Dec 2025 00:00:00 -0500_  
  arXiv:2512.08704v1 Announce Type: new 
Abstract: Background: Adolescence is a critical period of brain maturation and heightened vulnerability to cognitive and mental health disorders. Sleep plays a vital role in neurodevelopment, yet the mechanisms linking insufficient sleep to adverse brain and behavioral outcomes r…

- **[Resource and population dynamics in an agent-environment interaction model](https://arxiv.org/abs/2512.08762)**  
  _Wed, 10 Dec 2025 00:00:00 -0500_  
  arXiv:2512.08762v1 Announce Type: new 
Abstract: In any ecosystem, the conditions of the environment and the characteristics of the species that inhabit it are entangled, co-evolving in space and time. We introduce a model that couples active agents with a dynamic environment, interpreted as a nutrient source. Agents…

- **[Dynamical compatibility for finite and infinite population models used in genetics](https://arxiv.org/abs/2512.08783)**  
  _Wed, 10 Dec 2025 00:00:00 -0500_  
  arXiv:2512.08783v1 Announce Type: new 
Abstract: Finite and infinite population models are frequently used in population dynamics. However, their interrelationship is rarely discussed. In this work, we examine the limits of large populations of the Moran process (a finite-population birth-death process) and the replic…

- **[Multi state neurons](https://arxiv.org/abs/2512.08815)**  
  _Wed, 10 Dec 2025 00:00:00 -0500_  
  arXiv:2512.08815v1 Announce Type: new 
Abstract: Neurons, as eukaryotic cells, have powerful internal computation capabilities. One neuron can have many distinct states, and brains can use this capability. Processes of neuron growth and maintenance use chemical signalling between cell bodies and synapses, ferrying che…

- **[A mathematical model of \textit{Culex} population abundance and the impact of vector control interventions in a patchy environment](https://arxiv.org/abs/2512.08842)**  
  _Wed, 10 Dec 2025 00:00:00 -0500_  
  arXiv:2512.08842v1 Announce Type: new 
Abstract: Recent mosquito-borne outbreaks have revealed vulnerabilities in our abatement programmes, raising concerns about how abatement-districts should choose optimal future control strategies. Spatial dissemination of vector-borne disease is strongly shaped by the movement of…

- **[Frequency Locking to Environmental Forcing Suppresses Oscillatory Extinction in Phage-Bacteria Interactions](https://arxiv.org/abs/2512.08224)**  
  _Wed, 10 Dec 2025 00:00:00 -0500_  
  arXiv:2512.08224v1 Announce Type: cross 
Abstract: Bacteriophage-bacteria interactions are central to microbial ecology, influencing evolution, biogeochemical cycles, and pathogen behavior. Most theoretical models assume static environments and passive bacterial hosts, neglecting the joint effects of bacterial traits…

- **[Neural Ordinary Differential Equations for Simulating Metabolic Pathway Dynamics from Time-Series Multiomics Data](https://arxiv.org/abs/2512.08732)**  
  _Wed, 10 Dec 2025 00:00:00 -0500_  
  arXiv:2512.08732v1 Announce Type: cross 
Abstract: The advancement of human healthspan and bioengineering relies heavily on predicting the behavior of complex biological systems. While high-throughput multiomics data is becoming increasingly abundant, converting this data into actionable predictive models remains a bo…

- **[BeeTLe: An Imbalance-Aware Deep Sequence Model for Linear B-Cell Epitope Prediction and Classification with Logit-Adjusted Losses](https://arxiv.org/abs/2309.02071)**  
  _Wed, 10 Dec 2025 00:00:00 -0500_  
  arXiv:2309.02071v2 Announce Type: replace 
Abstract: The process of identifying and characterizing B-cell epitopes, which are the portions of antigens recognized by antibodies, is important for our understanding of the immune system, and for many applications including vaccine development, therapeutics, and diagnostic…

- **[Assessing the potential impact of environmental land management schemes on emergent infection disease risks](https://arxiv.org/abs/2311.07735)**  
  _Wed, 10 Dec 2025 00:00:00 -0500_  
  arXiv:2311.07735v2 Announce Type: replace 
Abstract: Financial incentives encourage the plantation of new woodland to increase habitat, biodiversity, carbon sequestration, as a contribution to meeting climate change and biodiversity conservation targets. Whilst these are largely positive effects, it is worth consideri…

- **[Ultra-large library screening with an evolutionary algorithm in Rosetta (REvoLd)](https://arxiv.org/abs/2404.17329)**  
  _Wed, 10 Dec 2025 00:00:00 -0500_  
  arXiv:2404.17329v2 Announce Type: replace 
Abstract: Ultra-large make-on-demand compound libraries now contain billions of readily available compounds. This represents a golden opportunity for in-silico drug discovery. One challenge, however, is the time and computational cost of an exhaustive screen of such large lib…

- **[Explainable AI for computational pathology identifies model limitations and tissue biomarkers](https://arxiv.org/abs/2409.03080)**  
  _Wed, 10 Dec 2025 00:00:00 -0500_  
  arXiv:2409.03080v3 Announce Type: replace 
Abstract: Deep learning models show promise in digital pathology, but their opaque decision-making processes limit trust and clinical adoption. To address this challenge, we present HIPPO, an explainable AI method for analyzing weakly-supervised multiple-instance learning (MI…

- **[AI-powered virtual tissues from spatial proteomics for clinical diagnostics and biomedical discovery](https://arxiv.org/abs/2501.06039)**  
  _Wed, 10 Dec 2025 00:00:00 -0500_  
  arXiv:2501.06039v2 Announce Type: replace 
Abstract: Spatial proteomics technologies have transformed our understanding of complex tissue architecture in cancer but present unique challenges for computational analysis. Each study uses a different marker panel and protocol, and most methods are tailored to single cohor…

- **[A Graph-based Approach to Variant Extraction from Sequences](https://arxiv.org/abs/2503.18472)**  
  _Wed, 10 Dec 2025 00:00:00 -0500_  
  arXiv:2503.18472v2 Announce Type: replace 
Abstract: Accurate variant descriptions are of paramount importance in the field of genomics. The domain is confronted with increasingly complex variants, e.g., combinations of multiple indels, making it challenging to generate proper variant descriptions directly from chromo…

- **[SSRCA: a novel machine learning pipeline to perform sensitivity analysis for agent-based models](https://arxiv.org/abs/2506.00168)**  
  _Wed, 10 Dec 2025 00:00:00 -0500_  
  arXiv:2506.00168v3 Announce Type: replace 
Abstract: Agent-based models (ABMs) are widely used in biology to understand how individual actions scale into emergent population behavior. Modelers employ sensitivity analysis (SA) algorithms to quantify input parameters' impact on model outputs, however, it is hard to perf…

- **[Feature Integration Spaces: Joint Training Reveals Dual Encoding in Neural Network Representations](https://arxiv.org/abs/2507.00269)**  
  _Wed, 10 Dec 2025 00:00:00 -0500_  
  arXiv:2507.00269v2 Announce Type: replace 
Abstract: Current sparse autoencoder (SAE) approaches to neural network interpretability assume that activations can be decomposed through linear superposition into sparse, interpretable features. Despite high reconstruction fidelity, SAEs consistently fail to eliminate polys…

- **[Life as a Categorical Information-Handling System: An Evolutionary Information-Theoretic Model of the Holobiont](https://arxiv.org/abs/2511.03346)**  
  _Wed, 10 Dec 2025 00:00:00 -0500_  
  arXiv:2511.03346v2 Announce Type: replace 
Abstract: Living systems can be understood as organized entities that capture, transform, and reproduce information. Classical gene-centered models explain adaptation through frequency changes driven by differential fitness, yet they often overlook the higher-order organizati…

- **[Prot2Token: A Unified Framework for Protein Modeling via Next-Token Prediction](https://arxiv.org/abs/2505.20589)**  
  _Wed, 10 Dec 2025 00:00:00 -0500_  
  arXiv:2505.20589v2 Announce Type: replace-cross 
Abstract: The diverse nature of protein prediction tasks has traditionally necessitated specialized models, hindering the development of broadly applicable and computationally efficient Protein Language Models (PLMs). In this work, we introduce Prot2Token, a unified fra…

- **[Surface Waves and Axoplasmic Pressure Waves in Action Potential Propagation: Fundamentally Different Physics or Two Sides of the Same Coin?](https://arxiv.org/abs/2505.24580)**  
  _Wed, 10 Dec 2025 00:00:00 -0500_  
  arXiv:2505.24580v2 Announce Type: replace-cross 
Abstract: In this commentary, we argue that El Hady and Machta's "surface wave" model for mechanical waves accompanying action potential (AP) propagation describes the same underlying process as the "axoplasmic pressure wave" model introduced earlier by Rvachev. Both mo…
